Tillotts Pharma AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tillotts Pharma AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7558
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tillotts Pharma AG (Tillotts) a subsidiary of Zeria Pharmaceutical Co Ltd is a healthcare solution provider that develops, licenses and markets pharmaceutical products, medical devices and diagnostics in the field of gastroenterology. The company’s products are used for the treatment of various diseases including ulcerative colitis, digestive systems and crohn’s disease, bowel spasms and others. Tillotts offers contract manufacturing services. It distributes its products through its affiliates and also through a network of distributors and licensees across Europe and the Middle East. The company has a presence in Czech Republic, Ireland, Sweden, Spain, Germany and the UK. Tillotts is headquartered in Rheinfelden, Switzerland.

Tillotts Pharma AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tillotts Pharma AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Tillotts Pharma Acquires Entocort from AstraZeneca 10
Partnerships 11
PendoPharm Enters into Distribution Agreement with Tillotts Pharma 11
Solid Form Solutions Enters Into Co-Promotion Agreement With Tillotts Pharma 12
Licensing Agreements 13
Tillotts Pharma Enters into Licensing Agreement with BioWa and Lonza 13
Tillotts Pharma Enters into Licensing Agreement with Inven2 14
Tillotts Pharma Enters into Licensing Agreement with Numab 15
Tillotts Pharma Amends Licensing Agreement with Cancer Prevention Pharma 16
Tillotts Pharma AG – Key Competitors 18
Tillotts Pharma AG – Key Employees 19
Tillotts Pharma AG – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Strategy And Business Planning 21
Mar 05, 2018: Tillotts Pharma opens new, state-of-the-art office in Rheinfelden, Switzerland 21
Feb 23, 2017: Tillotts Pharma in Germany Dedicated to Gastrointestinal Health 22
Corporate Communications 23
May 04, 2018: Tillotts Pharma Announces Resignation Of Prof. Dr. Ulrich Mittmann And Dr. Roberto Gradnik Step Down From Board 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Tillotts Pharma AG, Pharmaceuticals & Healthcare, Key Facts 2
Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tillotts Pharma AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tillotts Pharma AG, Deals By Therapy Area, 2012 to YTD 2018 8
Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tillotts Pharma Acquires Entocort from AstraZeneca 10
PendoPharm Enters into Distribution Agreement with Tillotts Pharma 11
Solid Form Solutions Enters Into Co-Promotion Agreement With Tillotts Pharma 12
Tillotts Pharma Enters into Licensing Agreement with BioWa and Lonza 13
Tillotts Pharma Enters into Licensing Agreement with Inven2 14
Tillotts Pharma Enters into Licensing Agreement with Numab 15
Tillotts Pharma Amends Licensing Agreement with Cancer Prevention Pharma 16
Tillotts Pharma AG, Key Competitors 18
Tillotts Pharma AG, Key Employees 19
Tillotts Pharma AG, Subsidiaries 20

List of Figures
Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tillotts Pharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Tillotts Pharma AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Program for Appropriate Technology in Health:医療機器:M&Aディール及び事業提携情報
    Summary Program for Appropriate Technology in Health (PATH) is a non-profit organization that improves health in women and children. The organization offers vaccines, drugs, diagnostics, devices, system and service innovations, and digital health solutions. It develops diagnostics for HIV and other …
  • Civica Group Limited:企業の戦略的SWOT分析
    Civica Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Varian Medical Systems, Inc.:戦略・SWOT・企業財務分析
    Varian Medical Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Varian Medical Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • AiVita Biomedical Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary AiVita Biomedical Inc (AiVita) is a biotechnology company developing novel stem cell technologies to develop cell-based treatments and healthcare products for the treatment of cancer, vision loss, and skincare formulations. Its lead therapeutic candidate is a patient-specific immunotherapy f …
  • Oberbank AG:企業の戦略・SWOT・財務分析
    Oberbank AG - Strategy, SWOT and Corporate Finance Report Summary Oberbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Thermalin Diabetes LLC-製薬・医療分野:企業M&A・提携分析
    Summary Thermalin Diabetes LLC (Thermalin) is an insulin analogs developer. The company develops concentrated insulin analog for the treatment of individuals with insulin resistance and for use in miniature insulin pumps. It develops both molecular and formulation strategies to produce an acting ana …
  • The Federal Bank Limited:企業の戦略・SWOT・財務分析
    The Federal Bank Limited - Strategy, SWOT and Corporate Finance Report Summary The Federal Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • UPM-Kymmene Corporation (UPM):企業の財務・戦略的SWOT分析
    UPM-Kymmene Corporation (UPM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Arlington Asset Investment Corp (AI):企業の財務・戦略的SWOT分析
    Summary Arlington Asset Investment Corp (AAIC) is an investment firm that offers asset management and investment services. The firm acquires and holds mortgage-related assets. It acquires residential mortgage-backed securities issued by the US government agencies. AAIC also acquires mortgage-backed …
  • Oilex Ltd (OEX):石油・ガス:M&Aディール及び事業提携情報
    Summary Oilex Ltd (Oilex) is an oil and gas company that acquires, explores and develops petroleum resources. The company’s projects in Australia include STP-EPA-0106, STP-EPA-0131, and STP-EPA-0107. Its STP-EPA-0106 project is located in onshore north-western Australia. Oilex’s Indian projects are …
  • Teollisuuden Voima Oyj:企業の戦略的SWOT分析
    Teollisuuden Voima Oyj - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • BioStar Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BioStar Pharmaceuticals Inc (BioStar) is a developer, manufacturer and marketer of pharmaceutical and healthcare supplement products for various diseases and conditions. The company offers products such as huangyangning tablets, hyperthyroidism capsules, danshen granule, aoxing oleanolic aci …
  • Shoprite Holdings Ltd:企業の戦略・SWOT・財務情報
    Shoprite Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Shoprite Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • NGM Biopharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NGM Biopharmaceuticals Inc (NGM Bio) is a clinical-stage biopharmaceutical company that develops pipeline of biological therapeutics for the treatment of cardio-metabolic, immuno-oncology, retinal and liver diseases. The company’s pipeline products include NGM282, NGM386, NGM395, NGM621, NGM …
  • RHI Magnesita N.V.:企業の戦略・SWOT・財務情報
    RHI Magnesita N.V. - Strategy, SWOT and Corporate Finance Report Summary RHI Magnesita N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Standard Alliance Insurance Plc:企業の戦略・SWOT・財務分析
    Standard Alliance Insurance Plc - Strategy, SWOT and Corporate Finance Report Summary Standard Alliance Insurance Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Catholic Health Initiatives:企業の戦略・SWOT・財務情報
    Catholic Health Initiatives - Strategy, SWOT and Corporate Finance Report Summary Catholic Health Initiatives - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates:企業の戦略・SWOT・財務情報
    Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates - Strategy, SWOT and Corporate Finance Report Summary Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • Plains All American Pipeline LP (PAA):石油・ガス:M&Aディール及び事業提携情報
    Summary Plains All American Pipeline LP (PAAP) is a midstream energy company. It owns and operates the transportation, storage, terminalling and marketing of crude oil and refined petroleum products. The company also carries out the storage of natural gas, and processing, transportation, fractionati …
  • AVI Limited:企業の戦略・SWOT・財務情報
    AVI Limited - Strategy, SWOT and Corporate Finance Report Summary AVI Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆